Rami Komrokji, MD, Moffitt Cancer Center
Advertisement
Articles by Rami Komrokji, MD, Moffitt Cancer Center
Advertisement
Latest Updated Articles
The Role of Supportive CarePublished: November 18th 2020 | Updated:
Heterogeneity and Presentation of MDSPublished: November 18th 2020 | Updated:
Ensuring an Accurate DiagnosisPublished: November 18th 2020 | Updated:
The Role of Hypomethylating Agents and TransplantationPublished: November 18th 2020 | Updated:
The Future of MDS ManagementPublished: November 18th 2020 | Updated:
Overview of Luspatercept-aamt as MDS TreatmentPublished: November 18th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
5